These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19379773)

  • 1. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
    Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
    Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for altered TLR gene expression in association with increased expression of CD200R in the induction of mucosal tissue CD4(+) Treg in aged mice following gavage with a liver extract along with intramuscular monophosphoryl lipid A (MPLA) injection.
    Khatri I; Alexander C; Brandenburg K; Fournier K; Lee L; Mach JP; Rietschel ET; Ulmer AJ; Waelli T; Gorczynski RM
    Exp Gerontol; 2008 Aug; 43(8):771-81. PubMed ID: 18555631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM
    Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.
    Gorczynski RM; Lee L; Boudakov I
    Transplantation; 2005 Feb; 79(4):488-91. PubMed ID: 15729177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.
    Gorczynski RM; Lee L; Boudakov I
    Transplantation; 2005 May; 79(9):1180-3. PubMed ID: 15880066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of dendritic cells with regulatory properties.
    Ureta G; Osorio F; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2007 Apr; 39(3):633-7. PubMed ID: 17445563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
    Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
    Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
    Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells generated with Flt3L and exposed to apoptotic cells lack induction of T cell anergy and Foxp3⁺ regulatory T cell conversion in vitro.
    Pletinckx K; Lutz MB
    Immunobiology; 2014 Mar; 219(3):230-40. PubMed ID: 24252473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an expressed truncated form of CD200, CD200tr, which is a physiologic antagonist of CD200-induced suppression.
    Chen Z; Chen DX; Kai Y; Khatri I; Lamptey B; Gorczynski RM
    Transplantation; 2008 Oct; 86(8):1116-24. PubMed ID: 18946351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.